Stay updated with breaking news from Haystack Oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fitch Ratings has affirmed Quest Diagnostics, Inc.'s Long-Term Issuer Default Rating , senior unsecured revolving facility and senior unsecured notes at 'BBB'. The Rating Outlook remains...
/PRNewswire/ -- PinkDx, Inc., an early-stage company focused on positively impacting the health of women throughout their life journey, today launched with $40...
Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.04, expectations were $1.86.
Insightful Analysis of Quest Diagnostics Inc's Market Position and Future Prospects
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2023 Earnings Call Transcript February 1, 2024 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.15, expectations were $2.14. Quest Diagnostics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Quest Diagnostics Fourth […]